A novel mechanism for anti‐EGFR antibody action involves chemokine‐mediated leukocyte infiltration
Hoffmann, Thomas K., Schirlau, Kerstin, Sonkoly, Enikö
, Brandau, Sven
, Lang, Stephan, Pivarcsi, Andor
, Balz, Vera, Müller, Anja, Homey, Bernhard, Boelke, Edwin, Reichert, Torsten, Friebe‐Hoffmann, Ulrike, Greve, Jens, Schuler, Patrick, Scheckenbach, Kathrin, Schipper, Jörg, Bas, Murat, Whiteside, Theresa L. and Bier, Henning
(2009)
A novel mechanism for anti‐EGFR antibody action involves chemokine‐mediated leukocyte infiltration.
International Journal of Cancer 124 (11), pp. 2589-2596.
Date of publication of this fulltext: 19 Dec 2024 12:06
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | International Journal of Cancer | ||||
| Publisher: | WILEY | ||||
|---|---|---|---|---|---|
| Place of Publication: | HOBOKEN | ||||
| Volume: | 124 | ||||
| Number of Issue or Book Chapter: | 11 | ||||
| Page Range: | pp. 2589-2596 | ||||
| Date | 2009 | ||||
| Institutions | Medicine > Lehrstuhl für Mund-, Kiefer- und Gesichtschirurgie | ||||
| Identification Number |
| ||||
| Keywords | GROWTH-FACTOR RECEPTOR; SQUAMOUS-CELL CARCINOMAS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; NECK-CANCER; MONOCLONAL-ANTIBODY; MALIGNANT TRANSFORMATION; CHEMOTACTIC PROTEIN-1; MATUZUMAB EMD-72000; SIGNAL-TRANSDUCTION; SKIN INFLAMMATION; epidermal growth factor receptor; head and neck cancer; spheroids; immune cells; PBMC; chemotaxis | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 67126 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric